The E. coli AntiMicrobial Satellite(EcAMSat) mission will investigate space microgravity affects on the antibiotic resistance of E. coli, a bacterial pathogen responsible for urinary tract infection in humans and animals. EcAMSat is being developed through a partnership between NASAs Ames Research Center and the Stanford University School of Medicine. Dr. A.C. Matin is the Stanford University Principal Investigator. EcAMSat will investigate spaceflight effects on bacterial antibiotic resistance and its genetic basis. Bacterial antibiotic resistance may pose a danger to astronauts in microgravity, where the immune response is weakened. Scientists believe that the results of this experiment could help design effective countermeasures to protect astronauts health during long duration human space missions.
NASA FACTS: E. coli AntiMicrobial Satellite (EcAMSat)
2013-04-24
Sonstige
Keine Angabe
Englisch
E. coli AntiMicrobial Satellite (EcAMSat)
NTRS | 2014
|NTIS | 2013
|NTIS | 1977
NTRS | 2013
|